Health Condition 1: M258- Other specified joint disorders
Conditions
Interventions
Intervention1: Impact of Pharmacist Intervention on Therapeutic Outcome and Quality of Life of Patients Suffering from Rheumatoid Arthritis - A Randomized Open Label Study: Impact of Pharmacist Interv
Sponsors
KAHER KLE COLLEGE OF PHARMACY
Arthritis Superspeciality Center Hubballi
Eligibility
Inclusion criteria
Inclusion criteria: Adults above 18years Patients receiving atleast one DMARD therapy Patients willing to participate and provide informed consent form
Exclusion criteria
Exclusion criteria: Patients with other autoimmune or inflammatory disorders. Patients who are unable or unwilling to provide informed consent. Pregnant or lactating women. Psychiatric patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate the impact of pharmacist intervention on disease activity using the DAS-28 (Disease Activity Score-28) and to assess the improvement in quality of life using SF 36 Scale in patients with RA. 2.To perform a Cost-Effectiveness Analysis (CEA) of the pharmacist intervention versus standard care in the management of RA. Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To assess the Knowledge, Attitude, & Practice (KAP) of patients regarding their disease, treatment regimen, & lifestyle before & after pharmacist intervention. 2.To conduct Drug Utilization Evaluation (DUE) of medications prescribed to RA patients, analyzing patterns, rationality, & adherence. Timepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactTRIVENI JAGADISH UMARANI
KLE Academy of Higher Education and Research Deemed to be University
Outcome results
None listed